In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy

Autoimmunity

Volumn 42, Issue 5, 2009, Pages 414-423

  Irman, Špela ^a   Miha, Škarabot ^b   Igor, Muševič ^a,c   Rozman, Blaž ^a   Božič, Borut ^a,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Annexin A5; Crystallization; Naturally derived phospholipids; P3 p6 crystal form; Thrombomodulatory function

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; LIPOCORTIN 5; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CRYSTALLIZATION; IN VITRO STUDY; LIPID VESICLE; MOLECULAR MODEL; PHOSPHOLIPID BILAYER;

ANNEXIN A5; CRYSTALLIZATION; FEMALE; HUMANS; LIPID BILAYERS; MICROSCOPY, ATOMIC FORCE; PHOSPHOLIPIDS; PLACENTA; PREGNANCY;

EID: 69649101640     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902785371     Document Type: Article

References (47)

1. Benz J, Hofmann A. Annexins: From structure to function. Biol Chem 1997;378:177-183.
2. Gerke V, Moss SE. Annexins and membrane dynamics. Biochim Biophys Acta 1997;1357:129-154.
3. Reutelingsperger CP, Hornstra G, Hemker HC. Isolation and partial purification of novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985;151:625-629.
4. Romisch J, Seiffge D, Reiner G, Paques EP, Heimburger N. In vivo antithrombotic potency of placenta protein 4 (annexin V). Tromb Res 1991;61:93-104.
5. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Tromb Vasc Biol 2005;25:1776-1785.
6. Shoenfeld Y, Gerli R, Doria A, Matsuuda E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-3347. (Pubitemid 43739380)
7. Rand JH, Wu XX, Andree HA, Loockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the phospholipidantibody syndrome-a possible thrombogenic mechanism. N Engl J Med 1997;337:154-160.
8. Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C. Annexin A5 downregulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 2005;280:6028-6035.
9. Rojas E, Pollard HB, Haigler HT, Parra C, Burns AL. Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem 1990; 265:21207-21215.
10. Berendes R, Voges D, Demange D, Huber P, Burger A. Structure-function analysis of the ion channel selectivity filter in human annexin V. Science 1993;262:427-430.
11. Liemann S, Benz J, Burger A, Voges D, Hofmann A, Huber R. Structural and functional characterisation of the voltage sensor in the ion channel human annexin V. J Mol Biol 1996;258: 555-561.
12. van Heerde WL, de Groot PG, Reutelingsperger CPM. The Complexity of the phospholipid binding protein annexin V. Thromb Haemostas 1995;73:172-179.
13. Russo-Marie F. Annexin Vand phospholipid metabolism. Clin Chem Lab Med 1990;37:2287-2291.
14. Callahan MK, Williamson P, Schleger RA. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic tymocytes. Cell Death Differ 2000; 6:645-653.
15. Huber R, Romisch J, Paques E. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds calcium and membranes. EMBO J 1990;9:3867-3974.
16. Oling F, Sopkova-de Oliveira Santos J, Govorukhina N, Mazeres-Dubut C, Bergsma-Schutter W, Oostergetel G, Keegstra W, Lambert O, Lewit-Bentley A, Brisson A. Structure of membrane bound annexin A5 trimers: A hybrid cryo-EM-X-ray crystallography study. J Mol Biol 2000;304: 561-573.
17. Oling F, Bergsma-Schutter W, Brisson A. Trimers, dimers of trimers, trimers of trimers are common building blocks of annexin A5 two-dimensional crystals. J Struct Biol 1998;133: 55-63.
18. Richter RP, Lai Kee J, Tessier B, Tessier C, Brisson A. On the kinetics of adsorption and two dimensional self-assembly of annexin A5 on supported lipid bilayers. Biophys J 2005;89: 3372-3385.
19. Rand JH, Wu XX, Andree HA, Ross JB, Rusinova E, Gacon- Lema MG, Calandri C, Harpel PC. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: A "Lupus procoagulant" phenomen. Blood 1998;92:1652-1660.
20. Gašperšič N, Ambrožič A, Božič B, Majhenc J, Svetina S, Rozman B. Annexin A5 binding to giant phospholipid vesicles is differentialy affected by anti-b2-glycoprotein I and antiannexin A5 antibodies. Rheumatology 2007;46:81-86.
21. Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ. Antiphospholipid immunoglobulin G antibodies reduce annexin V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997; 177:918-923.
22. Rand JH, Wu XX, Lapinski R, van Heerde WL, Reutelingsperger CP, Chen PP, Ortel TL. Detection of antibodymediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 2004;104:2783-2790.
23. Rand JH, Arslan AA,Wu XX,Wein R, Mulholland J, Shah M, van Heerde WL, Reutelingsperger CP, Lockwood CJ, Kuczynski E. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006;194:182-188. (Pubitemid 43017794)
24. Reviakine I, Bergsma-Schutter W, Mozorov AN, Brisson A. Two-dimensional crystallization of annexin A5 on phospholipid bilayers and monolayers: A solid-solid phase transition between crystal forms. Langmuir 2001;17:1680-1686.
25. Reviakine I, Bergsma-Schutter W, Marezes-Dubut C, Govorukhina N, Brisson A. Surface topography of the p3 and p6 annexin v crystal forms determined by atomic force microscopy. J Struct Biol 2000;131:234-239.
26. Reviakine I, Bergsma-Schutter W, Brisson A. Growth of protein 2D crystals on supported planar lipid bilayers imaged in situ by AFM. J Struct Biol 1998;121:356-361.
27. Binning G, Quoate CF, Gerber Ch. Atomic force microscope. Phys Rev Lett 1986;56:930-933.
28. Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR, Bovill EG, Taatjes DJ. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholpid bilayers: Evidence from atomic force microscopy. Am J Pathol 2003;163:1193-1200.
29. Klingler M, Demmelmair H, Larque E, Koletzko B. Analysis of FA contents in individual lipid fractions from human placenta tissue. Lipids 2003;38:561-566.
30. Vossen RC, van Dam-Mieras MC, Lemmens PJ, Hornstra G, Zwaal RF. Mambrane fatty acid composition and endothelial cell function properties. Biochim Biophys Acta 1991;1083: 243-251.
31. Benistant C, Dehouk MP, Fruchart JC, Cecchelli R, Lagarde M. Fatty acid composition of brain capilary endothelial cells: Effect of the coculture with astrocytes. J Lipid Res 1995;36:2311-2319.
32. Dodge JT, Phillips GB. Composition of phospholipids and phospholipid fatty acids and aldehydes in human red cells. J Lipid Res 1967;8:667-675.
33. Manku MS, Horrobin DF, Huang YS, Morse N. Fatty acids in plasma and red cell membranes in normal humans. Lipids 1983;18:906-908.
34. Božič B, Irman S, Gašperšič N, Kveder T, Rozman B. Antibodies against annexin A5: Detection pitfalls and clinical associations. Autoimmunity 2005;38:425-430.
35. Esposito G, Tamby MC, Chanseaud Y, Servettaz A, Guillevin L, Mouthon L. Anti-annexin V antibodies: Are they prothrombotič Autoimmun Rev 2005;4:55-60.
36. Capila I, Hernaiz MJ, Mo YD, Mealy TR, Campos B, Dedman JR, Linhardt RJ, Saton BA. Annexin-V heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces. Structure 2001;9:57-64.
37. Rand JH, Wu XX, Quinn AS, Taatjes DJ. Resistance to annexin A5 anticoagulant activity: A thrombogenic mechanism for the antiphospholipid syndrome. Lupus 2008;17: 922-930.
38. SeifertU. Configurations of fluid membranes and vesicles. Adv Phys 1997;46:13-137.
39. Lipowsky R, Seifert U. Adhesion of vesicles and membranes. Mol Cryst Liq Cryst 1991;202:17-25.
40. Reviakine I, Brisson A. Formation of supported phosholipid bilayers from unilamellar vesicles investigated by atomic force microscopy. Langmuir 2000;16:1806-1815.
41. Leonenko ZV, Carnini A, Cramb DT. Supported planar bilayer formation by vesicle fusion: The interaction of phospholipid vesicles with surfaces and the effect of gramicidin on bilayer properties using atomic force microscopy. Biochim Biophys Acta 2000;1509:131-147.
42. Richter RP, Brisson A. Following the formation of supported lipid bilayers on mica: A study combining AFM, QCM-D, and ellipsometry. Biophys J 2005;88:3422-3433.
43. Božič B, Kveder T, Stegnar M, Morosini-Berus E, Golja M, Peternel P, RozmanB. Influence of degraded phosphatidylserineon binding of antiphospholipid antibodies. Int Arch Allergy Immunol 1997;112:19-26.
44. Govorukhina N, Bergsma-Schutter A, Mazeres-Dubut C, Mazeres S, Drakopoulou E, Bystrykh L, Oling F, Mukhopadhyay A, Reviakine I, Lai Kee Him J, Brisson A. Selfassembly of annexin A5 on lipid membranes Annexins: Biological importance and annexin-related pathologies. Georgetown (TX): Landes Bioscience/Eurekah.com; 2003. p 37-55.
45. Arai T, Matsubayashi H, Sugi T, Kondo A, Shida M, Suzuki T, Izumi S-I, McIntyre JA, Makino T. Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. AJRI 2003;50: 202-208.
46. Fujimori A, Hosoya N. Phospholipids in human young placenta. J Biochem 1966;59:332-339.
47. Phillips GB, Dodge JT. Composition of phospholipids and of phospholipid fatty acids of human placenta. J Lipid Res 1967; 8:676-681.